In gene therapy, gene editing technologies can manipulate relevant genes in organoid models, knocking out phospholipid scramblase 1 (PLSCR1) to assess changes in susceptibility to viral infection, thereby informing the optimization of gene therapy strategies [372]. Here, PLSCR1 is linked to viral infectious disease.